BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11713803)

  • 1. Oligonucleotides as transcription factor decoys.
    Cho-Chung YS; Park YG; Lee YN
    Curr Opin Mol Ther; 1999 Jun; 1(3):386-92. PubMed ID: 11713803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia.
    Qiu J; Hu X; Nesic O; Grafe MR; Rassin DK; Wood TG; Perez-Polo JR
    J Neurosci Res; 2004 Jul; 77(1):108-18. PubMed ID: 15197744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor decoys: a new model for disease intervention.
    Mann MJ
    Ann N Y Acad Sci; 2005 Nov; 1058():128-39. PubMed ID: 16394132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the human brain natriuretic peptide gene by GATA-4.
    He Q; Mendez M; LaPointe MC
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E50-7. PubMed ID: 12067842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene.
    Tam RC; Lin CJ; Lim C; Pai B; Stoisavljevic V
    J Immunol; 1999 Oct; 163(8):4292-9. PubMed ID: 10510368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
    Nicolás M; Noé V; Ciudad CJ
    Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.
    Cho YS; Kim MK; Cheadle C; Neary C; Park YG; Becker KG; Cho-Chung YS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15626-31. PubMed ID: 12438686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
    Yoshida K; Inoue I
    Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation.
    Magnenat L; Blancafort P; Barbas CF
    J Mol Biol; 2004 Aug; 341(3):635-49. PubMed ID: 15288776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-responsive transcription factor-1 (MTF-1) selects different types of metal response elements at low vs. high zinc concentration.
    Wang Y; Lorenzi I; Georgiev O; Schaffner W
    Biol Chem; 2004 Jul; 385(7):623-32. PubMed ID: 15318811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid binding properties of SmZF1, a zinc finger protein of Schistosoma mansoni.
    Calzavara-Silva CE; Prosdocimi F; Abath FG; Pena SD; Franco GR
    Int J Parasitol; 2004 Oct; 34(11):1211-9. PubMed ID: 15491583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys.
    Nakamura H; Morishita R; Kaneda Y
    In Vivo; 2002; 16(1):45-8. PubMed ID: 11980360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
    Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
    Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
    Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.
    Cho WH; Lee SO; Kim HT; Ahn JD; Lee IK
    Transplant Proc; 2005; 37(1):77-9. PubMed ID: 15808553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.